Investigators in the Harper Cancer Research Institute (HCRI) are dedicated to conducting innovative and integrative research that confronts the complex challenges of cancer. Our programmatic structure fosters multi-disciplinary cancer research by promoting interactions among research groups with distinct expertise and by training young scientists to work across scientific fields. Clinical partnerships provide key translational insight and strengthen the mission of discovery.
HCRI Mission Statement:
Innovative and integrative research confronting the complex challenges of cancer
A new technology called spectral [color] computed tomography (spectral CT) is not only on the horizon, but it is also on the University of Notre Dame’s campus, where researchers are giving the phrase “in living color” a new meaning. Read more...
On Friday, September 11th, 2015, the 7th Annual Indiana Clinical and Translational Sciences Institute (CTSI) Meeting and Watanabe Prize Lecture took place in Indianapolis. This year’s theme was “Immune and Cell-based Therapies.”
The day-long, annual conference highlights advances in the clinical and translational sciences from the three partner universities, which include Indiana University, Purdue University, and the University of Notre Dame.…
Holly Weiss-Bilka, a postdoctoral associate in the Department of Biological Sciences, was awarded ‘best poster presentation’ in the postdoctoral division at the 2015 Indiana Clinical and Translational Sciences Institute (CTSI) annual meeting. As part of the award, Weiss-Bilka will receive $1,000 in research supply funds from the Indiana CTSI.
SAVE THE DATE!
Dr. Danny Welch, Professor and Chair of the Department of Cancer Biology at Kansas University, will be visiting campus on October 5.
Check back for updates on his seminar. …